Literature DB >> 19793207

Yield of diagnostic procedures for invasive fungal infections in neutropenic febrile patients with chest computed tomography abnormalities.

Dora Y Ho1, Margaret Lin, Joanna Schaenman, Fernando Rosso, Ann N C Leung, Steven E Coutre, Ramachandra R Sista, Jose G Montoya.   

Abstract

Haematological patients with neutropenic fever are frequently evaluated with chest computed tomography (CT) to rule out invasive fungal infections (IFI). We retrospectively analysed data from 100 consecutive patients with neutropenic fever and abnormal chest CT from 1998 to 2005 to evaluate their chest CT findings and the yield of diagnostic approaches employed. For their initial CTs, 79% had nodular opacities, with 24.1% associated with the halo sign. Other common CT abnormalities included pleural effusions (48%), ground glass opacities (37%) and consolidation (31%). The CT findings led to a change in antifungal therapy in 54% of the patients. Fifty-six patients received diagnostic procedures, including 46 bronchoscopies, 25 lung biopsies and seven sinus biopsies, with a diagnostic yield for IFI of 12.8%, 35.0% and 83.3%, respectively. In conclusion, chest CT plays an important role in the evaluation of haematological patients with febrile neutropenia and often leads to a change in antimicrobial therapy. Pulmonary nodules are the most common radiological abnormality. Sinus or lung biopsies have a high-diagnostic yield for IFI as compared to bronchoscopy. Patients with IFI may not have sinus/chest symptoms, and thus, clinicians should have a low threshold for performing sinus/chest imaging, and if indicated and safe, a biopsy of the abnormal areas.
© 2009 Blackwell Verlag GmbH.

Entities:  

Mesh:

Year:  2011        PMID: 19793207      PMCID: PMC3449060          DOI: 10.1111/j.1439-0507.2009.01760.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  35 in total

1.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

Authors:  P Therasse; S G Arbuck; E A Eisenhauer; J Wanders; R S Kaplan; L Rubinstein; J Verweij; M Van Glabbeke; A T van Oosterom; M C Christian; S G Gwyther
Journal:  J Natl Cancer Inst       Date:  2000-02-02       Impact factor: 13.506

Review 2.  Laboratory diagnosis of invasive aspergillosis.

Authors:  W W Hope; T J Walsh; D W Denning
Journal:  Lancet Infect Dis       Date:  2005-10       Impact factor: 25.071

3.  Diagnostic yield of bronchoscopy in histologically proven invasive pulmonary aspergillosis.

Authors:  F Reichenberger; J Habicht; P Matt; R Frei; M Solèr; C T Bolliger; P Dalquen; A Gratwohl; M Tamm
Journal:  Bone Marrow Transplant       Date:  1999-12       Impact factor: 5.483

Review 4.  An algorithmic approach to the diagnosis and management of invasive fungal rhinosinusitis in the immunocompromised patient.

Authors:  M B Gillespie; B W O'Malley
Journal:  Otolaryngol Clin North Am       Date:  2000-04       Impact factor: 3.346

5.  Pulmonary candidiasis after hematopoietic stem cell transplantation: thin-section CT findings.

Authors:  Tomás Franquet; Nestor L Müller; Kyung S Lee; Anastasia Oikonomou; Julia D Flint
Journal:  Radiology       Date:  2005-06-13       Impact factor: 11.105

6.  Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia.

Authors:  D Caillot; J F Couaillier; A Bernard; O Casasnovas; D W Denning; L Mannone; J Lopez; G Couillault; F Piard; O Vagner; H Guy
Journal:  J Clin Oncol       Date:  2001-01-01       Impact factor: 44.544

7.  Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer.

Authors:  Georgios Chamilos; Edith M Marom; Russell E Lewis; Michail S Lionakis; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2005-05-24       Impact factor: 9.079

8.  The utility of open lung biopsy in patients with hematologic malignancies.

Authors:  D A White; P W Wong; R Downey
Journal:  Am J Respir Crit Care Med       Date:  2000-03       Impact factor: 21.405

9.  Galactomannan does not precede major signs on a pulmonary computerized tomographic scan suggestive of invasive aspergillosis in patients with hematological malignancies.

Authors:  M Weisser; C Rausch; A Droll; M Simcock; P Sendi; I Steffen; C Buitrago; S Sonnet; A Gratwohl; J Passweg; U Fluckiger
Journal:  Clin Infect Dis       Date:  2005-09-12       Impact factor: 9.079

10.  Initial CT manifestations of invasive pulmonary aspergillosis in 45 non-HIV immunocompromised patients: association with patient outcome?

Authors:  Marius Horger; Holger Hebart; Hermann Einsele; Claudia Lengerke; C D Claussen; Reinhard Vonthein; Christina Pfannenberg
Journal:  Eur J Radiol       Date:  2005-01-28       Impact factor: 3.528

View more
  5 in total

1.  Biopsy procedures for molecular tissue diagnosis of invasive fungal infections.

Authors:  Cornelia Mrazek; Cornelia Lass-Flörl
Journal:  Curr Infect Dis Rep       Date:  2011-12       Impact factor: 3.725

2.  CT-guided Core-Needle Biopsy of the Lung Is Safe and More Effective than Fine-Needle Aspiration Biopsy in Patients with Hematologic Malignancies.

Authors:  Gaurav V Watane; Mark M Hammer; Maria F Barile
Journal:  Radiol Cardiothorac Imaging       Date:  2019-12-19

3.  Missed diagnosis and misdiagnosis of infectious diseases in hematopoietic cell transplant recipients: an autopsy study.

Authors:  Ashrit Multani; Libby S Allard; Tamna Wangjam; R Alejandro Sica; David J Epstein; Andrew R Rezvani; Dora Y Ho
Journal:  Blood Adv       Date:  2019-11-26

4.  Evaluation of multiplex PCR in first episodes of febrile neutropenia as a tool to improve early yeast diagnosis in leukemic/preleukemic patients.

Authors:  H Teixeira; L Silva; J J F Magalhães; C Matias; J F F Magalhães; J M A Lyra; V Magalhães; N Lucena-Silva; H R L Melo; M B Jucá; C A A Brito
Journal:  Support Care Cancer       Date:  2014-06-05       Impact factor: 3.603

5.  A clinical approach to respiratory disease in patients with hematological malignancy, with a focus on respiratory infection.

Authors:  J Periselneris; J S Brown
Journal:  Med Mycol       Date:  2019-06-01       Impact factor: 4.076

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.